HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Howard L Weiner Selected Research

Atrophy

6/2023Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study.
1/2019MRI phenotypes in MS: Longitudinal changes and miRNA signatures.
12/2017A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
5/2017A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
1/2017Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
4/2016Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis.
11/2014MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
10/2014An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Howard L Weiner Research Topics

Disease

77Multiple Sclerosis
04/2024 - 01/2002
36Tuberous Sclerosis (Bourneville's Disease)
08/2023 - 05/2003
29Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 02/2002
27Inflammation (Inflammations)
04/2024 - 09/2002
23Alzheimer Disease (Alzheimer's Disease)
05/2024 - 12/2002
23Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2002
22Epilepsy (Aura)
01/2024 - 01/2004
17Neoplasms (Cancer)
11/2021 - 04/2002
15Seizures (Absence Seizure)
01/2023 - 01/2004
13Drug Resistant Epilepsy
08/2023 - 01/2004
11Infections
04/2024 - 06/2005
10Relapsing-Remitting Multiple Sclerosis
07/2022 - 05/2007
8Atrophy
06/2023 - 10/2014
7Disease Progression
11/2022 - 04/2008
7Stroke (Strokes)
01/2022 - 12/2003
7Arthritis (Polyarthritis)
01/2022 - 09/2002
7Astrocytoma (Pilocytic Astrocytoma)
07/2014 - 05/2003
6Neuroinflammatory Diseases
01/2023 - 09/2009
6Autoimmune Diseases of the Nervous System
01/2022 - 08/2005
5COVID-19
01/2023 - 10/2020
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2022 - 06/2013
5Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022 - 12/2002
5Hypersensitivity (Allergy)
01/2022 - 08/2005
5Atherosclerosis
01/2022 - 09/2002
5Asthma (Bronchial Asthma)
01/2022 - 01/2002
5Rheumatoid Arthritis
12/2020 - 08/2005
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017 - 06/2006
5Colitis
10/2016 - 12/2002
4Uveitis
01/2022 - 08/2005
4Infarction (Infarctions)
11/2018 - 12/2003
3Cognitive Dysfunction
07/2023 - 02/2012
3Pneumonia (Pneumonitis)
01/2023 - 01/2021
3Thyroiditis
01/2022 - 08/2005
3Chronic Progressive Multiple Sclerosis
02/2021 - 01/2004
3Hydrocephalus (Hydrocephaly)
03/2020 - 01/2014
3Hamartoma
01/2018 - 07/2008
3Neurologic Manifestations (Neurological Manifestations)
01/2018 - 04/2014
3Glomerulonephritis
01/2018 - 05/2003
3Demyelinating Diseases (Demyelinating Disease)
12/2014 - 07/2007
3Meningoencephalitis
09/2009 - 03/2006
2Focal Cortical Dysplasia
01/2021 - 12/2018
2Brain Neoplasms (Brain Tumor)
03/2020 - 07/2012
2Glioblastoma (Glioblastoma Multiforme)
01/2019 - 05/2017
2Gliosis
12/2018 - 01/2008

Drug/Important Bio-Agent (IBA)

35trans-sodium crocetinate (crocetin)IBA
08/2023 - 01/2004
21Biomarkers (Surrogate Marker)IBA
04/2024 - 03/2008
16Monoclonal AntibodiesIBA
12/2023 - 06/2006
13Proteins (Proteins, Gene)FDA Link
04/2024 - 12/2002
13MicroRNAs (MicroRNA)IBA
06/2023 - 07/2012
12Interleukin-10 (Interleukin 10)IBA
11/2017 - 09/2002
10AntigensIBA
01/2022 - 02/2002
10Peptides (Polypeptides)IBA
11/2021 - 03/2003
9InterferonsIBA
01/2020 - 08/2004
9Glatiramer Acetate (Copaxone)FDA Link
11/2018 - 02/2002
8Amyloid beta-PeptidesIBA
05/2024 - 08/2003
7Transforming Growth Factor beta (TGF-beta)IBA
03/2009 - 03/2003
6LigandsIBA
07/2023 - 04/2002
6AutoantigensIBA
10/2016 - 09/2002
6Myelin-Oligodendrocyte GlycoproteinIBA
04/2008 - 05/2003
5Amyloid (Amyloid Fibrils)IBA
05/2024 - 03/2006
5Glial Fibrillary Acidic ProteinIBA
04/2024 - 01/2023
5Fingolimod Hydrochloride (FTY720)FDA Link
05/2023 - 12/2015
5Interferon beta-1aFDA Link
07/2022 - 11/2012
5CytokinesIBA
12/2020 - 12/2008
5Anticonvulsants (Antiepileptic Drugs)IBA
04/2020 - 01/2004
4Interleukin-27 (Interleukin 27)IBA
04/2023 - 08/2009
4Interleukin-17 (Interleukin 17)IBA
01/2023 - 12/2008
4foralumabIBA
01/2023 - 01/2021
4Alemtuzumab (Campath)FDA Link
10/2019 - 11/2012
4TOR Serine-Threonine KinasesIBA
01/2018 - 12/2013
4Natalizumab (Tysabri)FDA Link
05/2017 - 05/2007
4ChemokinesIBA
03/2008 - 05/2002
3N- fluoroacetyl- N- (2,5- dimethoxybenzyl)- 2- phenoxyanilineIBA
04/2024 - 09/2018
3GadoliniumIBA
01/2019 - 08/2004
3Interferon-betaIBA
11/2018 - 05/2002
3AutoantibodiesIBA
01/2018 - 11/2008
3BaclofenFDA LinkGeneric
01/2017 - 06/2005
3AntibodiesIBA
04/2016 - 03/2010
3GlycolipidsIBA
10/2014 - 01/2013
3OsteopontinIBA
04/2014 - 12/2008
3Messenger RNA (mRNA)IBA
09/2010 - 05/2005
3Myelin Basic ProteinIBA
03/2006 - 02/2002
2Interleukin-6 (Interleukin 6)IBA
01/2023 - 05/2006
2Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 10/2022
2RNA (Ribonucleic Acid)IBA
11/2021 - 09/2012
2Muromonab-CD3 (Muromonab CD3)FDA Link
07/2019 - 01/2017
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2019 - 11/2010
2Retinaldehyde (Retinal)IBA
01/2018 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2017 - 09/2010

Therapy/Procedure

42Therapeutics
10/2023 - 01/2002
11Immunotherapy
12/2023 - 05/2006
8Electrodes (Electrode)
02/2014 - 02/2005
7Oral Administration
11/2019 - 12/2003
6Intranasal Administration
12/2023 - 07/2009
6Transplantation
03/2016 - 06/2006
5Vagus Nerve Stimulation
12/2023 - 11/2009
2Craniotomy
04/2024 - 01/2009
2Lasers (Laser)
01/2024 - 01/2023
2Aftercare (After-Treatment)
11/2023 - 01/2013
2Catheters
08/2023 - 03/2011